These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11265224)

  • 1. [In vitro inhibition of Chlamydia trachomatis growth by liposome-encapsulated cyclines].
    Sangaré L; Morisset R; Ravaoarinoro M
    Pathol Biol (Paris); 2001 Feb; 49(1):53-6. PubMed ID: 11265224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline.
    Sangare L; Morisset R; Ravaoarinoro M
    J Med Microbiol; 1999 Jul; 48(7):689-693. PubMed ID: 10403420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice.
    Sangaré L; Morisset R; Gaboury L; Ravaoarinoro M
    J Antimicrob Chemother; 2001 Mar; 47(3):323-31. PubMed ID: 11222565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Chlamydia trachomatis growth in mouse fibroblasts by liposome-encapsulated tetracycline.
    al-Awadhi H; Stokes GV; Reich M
    J Antimicrob Chemother; 1992 Sep; 30(3):303-11. PubMed ID: 1452495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cationic liposome-encapsulated doxycycline in mice challenged with genital infection by Chlamydia trachomatis.
    Selliah S; Ravaoarinoro M
    Chemotherapy; 2004 Apr; 50(1):17-21. PubMed ID: 15084800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
    Dailloux M; Villemain P
    Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
    Samra Z; Rosenberg S; Soffer Y; Dan M
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
    Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
    Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE; Gaydos CA; Quinn TC
    Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
    Bailey JM; Heppleston C; Richmond SJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells.
    Eszik I; Lantos I; Önder K; Somogyvári F; Burián K; Endrész V; Virok DP
    J Microbiol Methods; 2016 Jan; 120():15-22. PubMed ID: 26578244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
    Busolo F; Conventi L
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of dirithromycin against Chlamydia trachomatis.
    Segreti J; Kapell KS
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal Encapsulation Increases the Efficacy of Azithromycin against
    Bogdanov A; Janovák L; Vraneš J; Meštrović T; Ljubin-Sternak S; Cseh Z; Endrész V; Burián K; Vanić Ž; Virok DP
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056934
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.
    Agacfidan A; Moncada J; Schachter J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1746-8. PubMed ID: 8239579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro.
    Ikeda-Dantsuji Y; Feril LB; Tachibana K; Ogawa K; Endo H; Harada Y; Suzuki R; Maruyama K
    Ultrason Sonochem; 2011 Jan; 18(1):425-30. PubMed ID: 20728399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
    Madhavan HN; Roy S; Malathy J
    Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.